CAPR
CAPRICOR THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$6.63
+6.42%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 32.40x
- P/S forward
- 4.81x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.57x
- Price / sales
- —
- Price / cash flow
- -3.71x
Enterprise value
- Enterprise value
- $238.6M
- EV / sales
- —
- EV / EBITDA
- 0.20x
- EV / EBIT
- -1.77x
- Market cap
- $385.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026